Palatin Technologies (PTN) director receives 2,400 new stock options
Rhea-AI Filing Summary
Palatin Technologies director Arlene Morris received a grant of stock options covering 2,400 shares of common stock with an exercise price of $7.70 per share. The options vest 50% on August 3, 2027 and 50% on August 3, 2028, and expire on August 3, 2037. After this award, she directly holds 3,497 stock options. The grant was approved by the Compensation Committee under Palatin’s 2011 Stock Incentive Plan and is reported under a Rule 10b5-1 trading arrangement.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
1 transaction reported
Mixed
1 txn
Insider
Morris Arlene
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Voting Trust | Stock Option (Right to Buy) F1 | 2,400 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,497 shares (Direct)
Footnotes (1)
- F1. Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.
Key Figures
Stock options granted: 2,400 shares
Exercise price: $7.70 per share
Options expiration: August 3, 2037
+3 more
6 metrics
Stock options granted
2,400 shares
Stock Option (Right to Buy) granted to director Arlene Morris
Exercise price
$7.70 per share
Conversion or exercise price of the granted stock option
Options expiration
August 3, 2037
Expiration date of the granted stock option
Options after transaction
3,497 options
Total derivative securities held directly after the grant
First vesting date
August 3, 2027
50% of the option grant vests on this date
Second vesting date
August 3, 2028
Remaining 50% of the option grant vests on this date
Key Terms
Stock Option (Right to Buy), 2011 Stock Incentive Plan, Compensation Committee, voting trust
4 terms
Stock Option (Right to Buy) financial
"Security titled "Stock Option (Right to Buy)" reported as derivative"
2011 Stock Incentive Plan financial
"Stock Option granted under the 2011 Stock Incentive Plan as amended"
Compensation Committee financial
"The option was granted by the Compensation Committee on August 3, 2026"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
voting trust regulatory
"Transaction code Z described as deposit into or withdrawal from voting trust"
A voting trust is an arrangement where shareholders temporarily transfer their voting rights to one or more trusted individuals (trustees) who vote on company matters on their behalf. It matters to investors because it consolidates decision-making power—like handing the car keys to a single driver for a journey—which can stabilize leadership or push through strategic plans but also reduces individual shareholders’ direct influence and can affect the company’s direction and stock value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Palatin Technologies (PTN) report for director Arlene Morris?
Palatin Technologies reported that director Arlene Morris received a grant of 2,400 stock options to buy common shares. These options carry a $7.70 exercise price, vest in two equal installments in 2027 and 2028, and expire in 2037 under the 2011 Stock Incentive Plan.
What are the vesting terms of Arlene Morris’s new Palatin (PTN) stock options?
The 2,400 stock options granted to Arlene Morris vest as to 50% on August 3, 2027 and the remaining 50% on August 3, 2028. This two-year vesting schedule is specified in the grant under Palatin’s 2011 Stock Incentive Plan.
What is the exercise price and expiration date of the new PTN options granted to Arlene Morris?
The options granted to Arlene Morris have an exercise price of $7.70 per share and expire on August 3, 2037. This means she may exercise the right to buy Palatin common stock at $7.70 until that expiration date, subject to vesting.
How many Palatin Technologies (PTN) stock options does Arlene Morris hold after this Form 4 transaction?
Following this reported grant, Arlene Morris directly holds 3,497 stock options in Palatin Technologies. This figure reflects her total derivative securities of this type after receiving the new 2,400-option award disclosed in the Form 4.
Under what plan and approval was the PTN option grant to Arlene Morris made?
The stock option grant to Arlene Morris was made under Palatin’s 2011 Stock Incentive Plan, as amended, and was approved by the company’s Compensation Committee. The Form 4 notes the grant date as August 3, 2026, with specified vesting and expiration terms.
Was the Palatin (PTN) director option grant reported in connection with a Rule 10b5-1 trading arrangement?
Yes. The Form 4 for Palatin Technologies indicates the transaction is affirmed under a Rule 10b5-1 trading arrangement. This checkbox signals that the reported grant was made pursuant to a pre-established plan meeting Rule 10b5-1 conditions.